Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sona Nanotech Inc C.SONA

Alternate Symbol(s):  SNANF

Technology Scientific & Technical Instruments
Sona Nanotech Inc. is a nanotechnology life sciences company that has developed multiple methods for the manufacturing of various types of gold nanoparticles. The Company is engaged in the research and development of its technology for use in multiplex diagnostic testing platforms and biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of CTAB (cetyltrimethylammonium), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company leverages its core proprietary gold nanorod (GNR) manufacturing technology and laboratory assets to focus on the development of diagnostic tests and biologic reagents, and the advancement of its GNR intellectual property.


CSE:SONA - Post by User

Sona Nanotech Inc > August 6th
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(903)
•••
Comment by Moemoney42on Aug 18, 2020 7:53pm
173 Views
Post# 31425797

RE:RE:RE:RE:August 6th

RE:RE:RE:RE:August 6th
FPInvestor wrote: The idiot is back.. let me guess ? U sold at 10.40 and bought back at 9.35 ? When u wake up from your naps do u find tha u often wake up to your thump in your mouth and another in the a$$? Be honest ! We won't judge you

Hey numbskull... I happened to be on the golf course again today...didn't do any trading... so looks like you can't blame me for shorting.. LOL.. as people like you seem to think the only reason a stock goes down is for nefarious reasons of shorter and bashers.. LOL.. maybe you should wake up..! Just think how many times you could have bought your traders back below $10 from that $16 sell alert.. too bad.. so sad..! LOL..!
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities